Science

The role of Nectin-4 as a predictive biomarker across genitourinary malignancies

Umang Swami/X

Dec 27, 2024, 14:18

The role of Nectin-4 as a predictive biomarker across genitourinary malignancies

An article was published in Journal of Clinical Oncology by Umang Swami et al..

“Assessing Nectin-4 as a Predictive Biomarker in Urothelial Carcinoma and Other Genitourinary Malignancies”

Authors: Zeynep Irem Ozay, Chadi Hage Chehade, Neeraj Agarwal, and Umang Swami.

International Urology Cancer Summit shared about this article on X, adding:

“The role of Nectin-4 as a predictive biomarker across urothelial and other genitourinary malignancies: insights into its expression and therapeutic implications.”

The role of Nectin-4 as a predictive biomarker across genitourinary malignancies

cancer Chadi Hage Chehade genitourinary malignancies International Urology Cancer Summit Nectin-4 Neeraj Agarwal OncoDaily Oncology Umang Swami urothelial cancer Zeynep Irem Ozay

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

New Paper Alert Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience

Highlights from TTLC2025

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding